RCM
PASG icon

RA Capital Management’s Passage Bio PASG Stock Holding History

RA Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,132
Closed -$8.25M – 94
2020
Q4 		$8.25M Hold
16,132
– – 0.12% 72
2020
Q3 		$4.23M Hold
16,132
– – 0.08% 67
2020
Q2 		$8.82M Hold
16,132
– – 0.17% 50
2020
Q1 		$5.08M Buy
+16,132
New +$5.05M 0.16% 42

Other funds holding PASG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RA Capital Management's PASG Position: Q1 2021 in Review

RA Capital Management sold out of Passage Bio (PASG) in Q1 2021, closing a stake of 16,132 shares — an estimated $8.25M sold.

RA Capital Management first reported a position in PASG in Q1 2020 and held it in 4 quarters. The position peaked at $8.82M in Q2 2020. 89 funds tracked by Wall St. Rank hold PASG as of Q1 2021.

  • RA Capital Management reported no remaining Passage Bio position as of Q1 2021 after selling out during the quarter.
  • RA Capital Management sold 16,132 Passage Bio shares in Q1 2021, an estimated $8.25M.
  • RA Capital Management first reported a position in Passage Bio in Q1 2020 and held it in 4 quarters.
  • RA Capital Management's Passage Bio position peaked at $8.82M in Q2 2020.
  • 89 funds tracked by Wall St. Rank held Passage Bio as of Q1 2021.

Based on RA Capital Management's 13F filing for Q1 2021, filed 17 May 2021.